Figure 3.
![Subsequent ACR among participant with first ACR >100 mg/g. The median of the first episode of ACR >100 mg/g was 175.8 (IQR, 135-242), while next ACR was 117.3 (IQR, 64-292). Among the participants 9 (22%) has an increase (median increase, 72% [IQR, 13%-157%] and 32 [78%]) had a decrease (median decrease, 45% [IQR, 13%-74%]) in their susequent ACR.](https://ash.silverchair-cdn.com/ash/content_public/journal/bloodadvances/7/22/10.1182_bloodadvances.2023010101/3/blooda_adv-2023-010101-gr3.jpeg?Expires=1724242577&Signature=fErOaKl7wPF~AyXik~ExmTNBuY-9cmDjzjDInGgjuDm~YQ-6mqBph4VwbJ5Eb-WjUdNo3JAGzawk9BQGkdSbnZYwDe5zODCe~uCP8O5xs2DJteOBG0zv4MDdFOlLol8BRXzEVtw1TsD1qxDQKjm2a1h723YLdbz0Z3Br8kFrJr1IPd2jfyX50R7VjuyDu1a8r9LOxYChy8ac4blfNf~3V-UzM6ZcVPFuI~CvPHTFfiFae8KprZyeAyWqFDNhfjYvW9hrBIYAentqZRRaNLrQaCwZ~af8bVKaBG57KTFdmk8eZu4YWXnG4n7d65gUuzAmAnXpjEUsGmVvWfLchTm7~w__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Subsequent ACR among participant with first ACR >100 mg/g. The median of the first episode of ACR >100 mg/g was 175.8 (IQR, 135-242), while next ACR was 117.3 (IQR, 64-292). Among the participants 9 (22%) has an increase (median increase, 72% [IQR, 13%-157%] and 32 [78%]) had a decrease (median decrease, 45% [IQR, 13%-74%]) in their susequent ACR.
